The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Hypoxia signalling in cancer and approaches to enforce tumour regression
Abstract
Tumour cells emerge as a result of genetic alteration of signal circuitries promoting cell growth and survival, whereas their expansion relies on nutrient supply. Oxygen limitation is central in controlling neovascularization, glucose metabolism, survival and tumour spread. This pleiotropic action is orchestrated by hypoxia-inducible factor (HIF), which is a master transcriptional factor in nutrient stress signalling. Understanding the role of HIF in intracellular pH (pH(i)) regulation, metabolism, cell invasion, autophagy and cell death is crucial for developing novel anticancer therapies. There are new approaches to enforce necrotic cell death and tumour regression by targeting tumour metabolism and pH(i)-control systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The affinity of PHDs and FIH-1 for oxygen differs and, since FIH-1 has a higher affinity (lower K m ) for oxygen, PHDs are thought to be more rapidly inhibited in low oxygen conditions (Pouyssegur et al., 2006).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Pouyssegur et al., 2006
In the citing paper
“this is recognized to have profound effects on the tumor metabolism (92)(93)(94)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [93]
In the citing paper
“O 2 tension in the center of solid tumors may be so low that cells essentially become anoxic”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [93]
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedThe biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Flagged first, then by citations
1 of the 104 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,002
Ratnayake, R., Gunasekera, S. P., Ma, J., Dang, L. H., Carney, T. J., Paul, V. J., & Luesch, H. (2020) · ChemBioChem · doi:10.1002/cbic.202000180 · Cited by 27
Cao, D., Li, H., Luo, Y., Feng, N., & Ci, T. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.043 · Cited by 27
A vasculature-centric approach to developing novel treatment options for glioblastoma
Wirsching, H., Roth, P., & Weller, M. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1881062 · Cited by 26
Lee, Y., Cherng, Y., Yang, S., Liu, S., Chen, T.-L., & Chen, R. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5558618 · Cited by 28
Bajrai, L. H., Sohrab, S. S., Mobashir, M., Kamal, M. A., Rizvi, M. M. A., & Azhar, E. I. (2021) · Scientific Reports · doi:10.1038/s41598-021-98031-7 · Cited by 30
Metwally, N. H., & El-Desoky, E. A. (2023) · ACS Omega · doi:10.1021/acsomega.2c06954 · Cited by 27
Li, T., Han, L., Ma, S., Lin, W., Ba, X. W., Yan, J., Huang, Y., Tu, S., & Qin, K. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1140325 · Cited by 27
The Effect of Cell–Matrix Interactions and Aging on the Malignant Process
Labat‐Robert, J., & Robert, L. (2007) · Advances in cancer research · doi:10.1016/s0065-230x(06)98007-5 · Cited by 27
Hypoxia attenuates the proinflammatory response in colon cancer cells by regulating IκB
Müller-Edenborn, K., Léger, K., Garzon, J. F. G., Oertli, C., Mirsaidi, A., Richards, P. J., Rehrauer, H., Spielmann, P., Hoogewijs, D., Borsig, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3961 · Cited by 27
Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
Smeland, E., Kilvaer, T. K., Sørbye, S. W., Valkov, A., Andersen, S., Bremnes, R. M., Busund, L., & Dønnem, T. (2012) · Sarcoma · doi:10.1155/2012/541650 · Cited by 27
HIF-1–Dependent Stromal Adaptation to Ischemia Mediates In Vivo Tumor Radiation Resistance
Schwartz, D. L., Bankson, J. A., Bidaut, L. M., He, Y., Williams, R. R., Lemos, R., Thitai, A. K., Oh, J., Volgin, A., Soghomonyan, S., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0469 · Cited by 27
Cancer cell aggregate hypoxia visualized in vitro via biocompatible fiber sensors
Xue, R., Nelson, M. T., Teixeira, S. A., Viapiano, M. S., & Lannutti, J. J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.055 · Cited by 27
Hypoxia inducible factor-1 alpha and multiple myeloma.
Bhaskar, A., & Tiwary, B. N. (2016) · PubMed · Cited by 27
Zhang, P., Li, H., Cheng, J., Sun, A., Wang, L., Мирчевска, Г., Calderone, R., & Li, D. (2017) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2017.11.002 · Cited by 26
Mehdi, M., Menon, M. K. C., Seyoum, N., Bekele, M., Tigeneh, W., & Seifu, D. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6039453 · Cited by 27
Zhu, S., Deng, S.-J., He, C., Liu, M., Chen, H., Zeng, Z., Zhong, J., Zeng, Y., Deng, S., Wu, H., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5089 · Cited by 27
Eyrich, N. W., Potts, C. R., Robinson, M. H., Maximov, V. D., & Kenney, A. M. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00268-18 · Cited by 27
Sihn, G., Walter, T., Klein, J.-C., Quéguiner, I., Iwao, H., Nicolau, C. S., Lehn, J., Corvol, P. L., & Gasc, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.079 · Cited by 27
Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model
Brader, P., Riedl, C. C., Woo, Y., Ponomarev, V., ZANZONICO, P. B., Wen, B., Cai, S., Hricak, H., Fong, Y., Blasberg, R., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0432 · Cited by 27
England, R., Masiá, E., Giménez, V., Lucas-Domínguez, R., & Vicent, M. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.017 · Cited by 26
An Early Diagnostic Tool for Diabetic Peripheral Neuropathy in Rats
Kambiz, S., van Neck, J. W., Cosgun, S. G., van Velzen, M. H. N., Janssen, J. A. M. J. L., Avazverdi, N., Hovius, S. E. R., & Walbeehm, E. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126892 · Cited by 26
Kim, A., & Yeul, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01455 · Cited by 26
Activation of amino acid metabolic program in cardiac HIF1-alpha-deficient mice
Menendez-Montes, I., Escobar, B., Gómez, M. J., Albendea-Gomez, T., Palacios, B., Bonzón‐Kulichenko, E., Izquierdo-García, J. L., Alonso, A. V., Ferrarini, A., Jiménez‐Borreguero, L. J., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102124 · Cited by 25
Schneider, M. A., Linecker, M., Fritsch, R., Muehlematter, U. J., Stocker, D., Pestalozzi, B. C., Samaras, P., Jetter, A., Kron, P., Petrowsky, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24069-w · Cited by 26
Brown, M., Holmes, H. L., Rakshit, K., Javeed, N., Her, T. K., Stiller, A. A., Sen, S., Shull, G. E., Prakash, Y. S., Romero, M. F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142365 · Cited by 26
Li, Z., He, Y., Li, Y., Li, J., Zhao, H., Guan-bing, S., Miyagishi, M., Wu, S., & Kasim, V. (2021) · Oncogene · doi:10.1038/s41388-021-02063-2 · Cited by 26
Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma
Liu, D., Hu, Z., Jiang, J., Zhang, J., Hu, C., Huang, J., & Wei, Q. (2022) · Scientific Reports · doi:10.1038/s41598-022-05103-3 · Cited by 24
Wang, Q., Serda, M., Li, Q., & Sun, T. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300138 · Cited by 26
Kim, B. S., Lee, K., Jung, H. J., Bhattarai, D., & Kwon, H. J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.031 · Cited by 26
PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
Ameln, A. K., Prade, I., Großer, M., Kettelhake, A., Rezaei, M., Chavakis, T., Flamme, I., Wielockx, B., & Breier, G. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0201 · Cited by 26
Hu, J., Stiehl, D. P., Setzer, C., Wichmann, D., Shinde, D. A., Rehrauer, H., Hradecky, P., Gassmann, M., & Gorr, T. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0090 · Cited by 28
Riemann, A., Güttler, A., Haupt, V., Wichmann, H., Reime, S., Bache, M., Vordermark, D., & Thews, O. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14965111926391 · Cited by 26
Wan, X., Liu, Y., Zhao, Y., Sun, X., Fan, D., & Guo, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184213 · Cited by 27
The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension
Bertero, T., Perk, D., & Chan, S. Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1615438 · Cited by 26
Combination of immunotherapy with anaerobic bacteria for immunogene therapy of solid tumours
Xu, J., Liu, X. S., Zhou, S., & Wei, M. Q. (2009) · Griffith Research Online · Cited by 26
Balamurugan, K., Luu, V.-D., Kaufmann, M., Hofmann, V. S., Boysen, G., Barth, S., Bordoli, M. R., Stiehl, D. P., Moch, H., Schraml, P., et al. (2009) · Oncogene · doi:10.1038/onc.2009.186 · Cited by 26
Hypoxia-induced Wnt5a-secreting fibroblasts promote colon cancer progression
Harada, A., Yasumizu, Y., Harada, T., Fumoto, K., Sato, A., Maehara, N., Sada, R., Matsumoto, S., Nishina, T., Takeda, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58748-9 · Cited by 25
The paradox of elongation factor 4: highly conserved, yet of no physiological significance?
Zhang, D., & Qin, Y. (2013) · Biochemical Journal · doi:10.1042/bj20121792 · Cited by 25
Cancer Exosomes as Mediators of Drug Resistance
André, M. D. R., Pedro, A. B. P., & Lyden, D. C. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3347-1_13 · Cited by 25
Hantelys, F., Godet, A.-C., David, F., Tatin, F., Renaud-Gabardos, E., Pujol, F., Diallo, L. H., Ader, I., Ligat, L., Henras, A. K., et al. (2019) · eLife · doi:10.7554/elife.50094 · Cited by 25
Zhou, W., Yang, J., Saren, G., Zhao, H., Cao, K., Fu, S., Pan, X., Zhang, H., Wang, A., & Chen, X. (2020) · Theranostics · doi:10.7150/thno.44961 · Cited by 26
Jia, Y., Li, H., Wang, Y., Wang, J., Zhu, J., Wei, Y., Lu, L., Chen, X., & Mo, S. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60018 · Cited by 26
Wishart, G., Gupta, P., Nisbet, A., Schettino, G., & Velliou, E. G. (2021) · Cancers · doi:10.3390/cancers13236080 · Cited by 26
How germline genes promote malignancy in cancer cells
Bruggeman, J. W., Köster, J., van Pelt, A. M. M., Speijer, D., & Hamer, G. (2022) · BioEssays · doi:10.1002/bies.202200112 · Cited by 28
Long non-coding RNA Neat1 and paraspeckle components are translational regulators in hypoxia
Godet, A.-C., Roussel, É., David, F., Hantelys, F., Morfoisse, F., Alves, J., Pujol, F., Ader, I., Bertrand, É., Burlet‐Schiltz, O., et al. (2022) · eLife · doi:10.7554/elife.69162 · Cited by 27
Luo, X., Wei, M., Li, W., Zhao, H., Kasim, V., & Wu, S. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.86279 · Cited by 26
Baumann, R. P., Ishiguro, K., Penketh, P. G., Shyam, K., Zhu, R., & Sartorelli, A. C. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.02.019 · Cited by 25
Charpin, C., Tavassoli, F. A., Secq, V., Giusiano, S., Villeret, J., Garcia, S., Birnbaum, D., Bonnier, P., Lavaut, M., Boubli, L., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.27371 · Cited by 25
Transcriptional adaptation of neuroblastoma cells to hypoxia
Fredlund, E., Ovenberger, M., Borg, Å., & Påhlman, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.074 · Cited by 25
Li, T., Huang, S., Dong, M., Gui, Y., & Wu, D. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.03.007 · Cited by 25
Ilié, M., Lassalle, S., Long-Mira, É., Hofman, V., Zangari, J., Benaïm, G., Bozec, A., Guevara, N., Haudebourg, J., Birtwisle‐Peyrottes, I., et al. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1453-x · Cited by 25
Metabolic effects of antiangiogenic drugs in tumors: Therapeutic implications
Quintieri, L., Selmy, M., & Indraccolo, S. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.02.018 · Cited by 25
Zhang, S., Luo, X., Wan, F., & Lei, T. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0879-x · Cited by 27
Li, H., Zhou, L., & Dai, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25924 · Cited by 25
Isono, M., Sato, A., Asano, T., Okubo, K., & Asano, T. (2018) · Anticancer Research · doi:10.21873/anticanres.12620 · Cited by 25
Galiè, M., Farace, P., Nanni, C., Spinelli, A. E., Nicolato, E., Boschi, F., Magnani, P., Trespidi, S., Ambrosini, V., Fanti, S., et al. (2007) · Neoplasia · doi:10.1593/neo.07541 · Cited by 25
Ilié, M., Hofman, V., Zangari, J., Chiche, J., Mouroux, J., Mazure, N. M., Pouysségur, J., Brest, P., & Hofman, P. M. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.07.005 · Cited by 25
Self-citationConditional Inactivation of HIF-1 Using Intrabodies
Groot, A. J., Gort, E. H., van der Wall, E., van Diest, P. J., & Vooijs, M. (2008) · Analytical Cellular Pathology · doi:10.1155/2008/384945 · Cited by 25
Dihydroartemisinin inhibits melanoma migration and metastasis by affecting angiogenesis
Li, Z., Zhang, Q., Zhang, X., Jin, Q., Yue, Q., Li, N., Liu, H., Fujimoto, M., & Jin, G. (2023) · Phytotherapy Research · doi:10.1002/ptr.8065 · Cited by 24
Sensor-based cell and tissue screening for personalized cancer chemotherapy
Kleinhans, R., Brischwein, M., Wang, P., Becker, B., Demmel, F., Schwarzenberger, T., Zottmann, M., Wolf, P. S., Niendorf, A., & Wolf, B. A. (2012) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-011-0855-7 · Cited by 24
Yeh, S., Chang, C.-A., Li, C., Wang, L. H.-C., & Chen, B. (2019) · Oncotarget · doi:10.18632/oncotarget.26940 · Cited by 24
Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
Scholtes, M., de Jong, F. C., Zuiverloon, T. C. M., & Theodorescu, D. (2021) · Cancers · doi:10.3390/cancers13020288 · Cited by 24
Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma
Hedna, R., Kovacic, H., Pagano, A., Peyrot, V., Robin, M., Devred, F., & Breuzard, G. (2022) · Cancers · doi:10.3390/cancers14215386 · Cited by 25
Involvement of redox signalling in tumour cell dormancy and metastasis
Puente-Cobacho, B., Varela‐López, A., Quiles, J. L., & Ramírez, L. V. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10077-9 · Cited by 25
Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship
Ceranski, A. K., Carreño-Gonzalez, M. J., Ehlers, A. C., Colombo, M. V., Cidre‐Aranaz, F., & Grünewald, T. G. P. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01750-w · Cited by 25
Alessandrini, L., Astolfi, L., Daloiso, A., Sbaraglia, M., Mondello, T., Zanoletti, E., Franz, L., & Marioni, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310733 · Cited by 24
Crémer, J., Brohée, L., Dupont, L., Lefevre, C., Peiffer, R., Saarinen, A. M., Peulen, O., Bindels, L. B., Liu, J., Colige, A., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216306 · Cited by 24
Bioactive food components, cancer cell growth limitation and reversal of glycolytic metabolism
Keijer, J., Bekkenkamp‐Grovenstein, M., Venema, D. P., & Dommels, Y. E. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.08.007 · Cited by 25
Germline prognostic markers for urinary bladder cancer: Obstacles and opportunities
Chang, D. W., Gu, J. H., & Wu, X. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.04.003 · Cited by 24
Sumoylation of hypoxia inducible factor-1α and its significance in cancer
Li, J., Xu, Y., Jiao, H., Wang, W., Mei, Z., & Chen, G. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4685-3 · Cited by 25
Lim, J.-H., Choi, Y.-J., Cho, C., & Park, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.006 · Cited by 24
Ding, Z., Huang, Y.-J., Tang, J., Li, G., Jiang, P.-Q., & Wu, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3826 · Cited by 24
Plasminogen kringle 5 suppresses gastric cancer via regulating HIF-1α and GRP78
Fang, S., Hong, H., Li, L., He, D., Xu, Z., Shaoyuan, Z., Han, J., Wu, Q., Dai, Z., Cai, W., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.528 · Cited by 24
Wojnarowicz, P. M., Breznan, A., Arcand, S. L., Filali-Mouhim, A., Provencher, D. M., Mes‐Masson, A., & Tonin, P. N. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01134.x · Cited by 24
Wang, Y., Chen, J., Tang, B., Zhang, X., & Hua, Z. (2013) · Molecular and Clinical Oncology · doi:10.3892/mco.2013.90 · Cited by 24
Yeom, C. J., Chung, J., Kang, J. H., Jeon, Y. H., Kim, K. I., Jin, Y. N., Lee, Y. M., Jeong, J. M., & Lee, D. S. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.044461 · Cited by 24
Pouysségur, J., & López‐Barneo, J. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.02.001 · Cited by 24
Self-citationCatechol‐Isolated Atomically Dispersed Nanocatalysts for Self‐Motivated Cocatalytic Tumor Therapy
Wang, Y., Qiu, S., Wang, L., Ji, P., Guo, Y., Yao, H., Wei, C., Huo, M., & Shi, J. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202316858 · Cited by 24
Cao, W., Yuan, F., Liu, T., & Yin, R. H. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117900 · Cited by 23
Role of Autophagy and AMPK in Cancer Stem Cells: Therapeutic Opportunities and Obstacles in Cancer
Kovale, L. M., Singh, M. K., Kim, J., & Ha, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168647 · Cited by 24
GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy
Im, J. H., Kang, K. W., Kim, S. Y., Kim, Y. G., An, Y., Park, S., Jeong, B. H., Choi, S., Lee, J.-S., & Kang, K. W. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0949-2 · Cited by 23
Avnet, S., Chano, T., Massa, A., Bonuccelli, G., Lemma, S., Falzetti, L., Grisendi, G., Dominici, M., & Baldini, N. (2019) · PubMed Central · Cited by 23
Targeting Cancer Metabolism and Current Anti-Cancer Drugs
Sukjoi, W., Ngamkham, J., Attwood, P. V., & Jitrapakdee, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_2 · Cited by 23
Tang, P., Qu, W., Wang, T., Liu, M., Wu, D., Tan, L., & Zhou, H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.785185 · Cited by 23
Xu, Y.-R., Wang, A.-L., & Li, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.984525 · Cited by 23
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit
Kostecki, K. L., Iida, M., Crossman, B. E., Salgia, R., Harari, P. M., Bruce, J. Y., & Wheeler, D. L. (2024) · Cancers · doi:10.3390/cancers16020312 · Cited by 26
Bartkowiak, K., Riethdorf, S., & Pantel, K. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0067-6 · Cited by 23
Serafino, A., & Pierimarchi, P. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140205140152 · Cited by 23
Antidepressant fluoxetine and its potential against colon tumors
Stopper, H. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i1.11 · Cited by 23
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs
Cimini, A., d’Angelo, M., Benedetti, E., D’Angelo, B., Laurenti, G., Antonosante, A., Cristiano, L., Mambro, A. D., Barbarino, M., Castelli, V., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25421 · Cited by 22
Landon‐Brace, N., Cadavid, J. L., Latour, S., Co, I. L., Rodenhizer, D., Li, N. T., Wu, N. C., Bugbee, E., Chebotarev, A., Zhang, J., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202105349 · Cited by 21
Deciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin Action
Sun, J., Zhao, M., Jia, P., Lily, W., Wu, Y., Carissa, I., Zhou, Y., Bowton, E., Roden, D. M., Denny, J. C., et al. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004202 · Cited by 24
Su, Y., Liu, J., Tian, Y., Dong, H., Shi, M., Zhang, J., Li, W., Huang, Q., Xiang, N., Wang, C., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116427 · Cited by 23
Wang, P., Zhang, X., Liu, F., & Wang, W. (2025) · Research · doi:10.34133/research.0651 · Cited by 23
Engineering Melanoma Progression in a Humanized Environment In Vivo
Kiowski, G., Biedermann, T., Widmer, D. S., Civenni, G., Burger, C., Dummer, R., Sommer, L., & Ernst Reichmann, A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.275 · Cited by 23
Zarin, B., Rafiee, L., Daneshpajouhnejad, P., & Javanmard, S. H. (2021) · Tumor Biology · doi:10.3233/tub-200075 · Cited by 23
Nisar, M., Paracha, R. Z., Adil, S., Qureshi, S. N., & Janjua, H. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.875188 · Cited by 22
Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance
Sa, P., Sahoo, S. K., & Dilnawaz, F. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220922111336 · Cited by 23
mTOR Inhibitor for the Treatment of Hepatocellular Carcinoma
Kudo, M. (2011) · Digestive Diseases · doi:10.1159/000327565 · Cited by 22
Hashimoto, Y., Tazawa, H., Teraishi, F., Kojima, T., Watanabe, Y., Uno, F., Yano, S., Urata, Y., Kagawa, S., & Fujiwara, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039292 · Cited by 24
Metadata
- Authors
- Pouysségur, J., Dayan, F., & Mazure, N. M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Pouysségur, Jacques
- Venue
- Nature
- Published
- 2006-05-24
- Volume
- 441
- Issue
- 7092
- Pages
- 437-443
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2082483448
- Semantic Scholar
- 5bbdcf74ee4cdf263a532b6dbae0b8dd5efb9722
- Cited by
- 1,676
- References
- 104
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 48 · 2023: 75 · 2022: 85 · 2021: 97 · 2020: 87 · 2019: 77 · 2018: 81 · 2017: 68 · 2016: 85 · 2015: 80 · 2014: 103 · 2013: 104 · 2012: 89
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hypoxia signaling, hypoxia-inducible factor, tumor hypoxia, tumor regression, cancer metabolism, intracellular pH regulation, tumor angiogenesis, glucose metabolism, necrosis, autophagy, cell invasion, cancer therapy, tumor oxygenation
- MeSH terms
- Animals, Humans, Neoplasms, Neovascularization, Pathologic, Oxygen, Protein Kinases, Signal Transduction, Cell Hypoxia, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review